ComplianceOnline Webinar - FDA Warning Letter Closeout Program(November 18, Thursday 10:00 AM PST | 01:00 PM EST)

This FDA warning letter closeout program will discuss how to successfully complete warning letter close out program which will help firm to obtain a closeout letter from FDA.

Areas Covered in the seminar :

  • Outline of FDA enforcement and compliance scheme.
  • FDA inspection process.
  • Lead up to a warning letter - warning signs.
  • Warning letter issuance.
  • Company response to FDA warning letters.
  • What to avoid when dealing with FDA warning letters.
  • Correcting FDA warning letter closeout mistakes.

Who will benefit :
This seminar will give valuable help to FDA regulated Pharmaceutical, Medical Device, Biotech, Diagnostics and Biological manufacturers who have received, expect or fear an FDA-483 or Warning Letter. The staff members who will benefit include:

  • VP of Quality
  • Director of Quality
  • CEO, COO, President and other operating executives
  • Board of Directors
  • Quality managers and personnel
  • Internal auditors
  • Consultants

For Registration: